Regulatory Overview News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CAMBRIDGE, Mass., October 04, 2023--Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, today announced that it has raised $35 million in Series B funding, led by Kurma Partners’ Growth Opportunities Fund, with participation from existing investors Seroba Life Sciences and Irish, U.S. and Canadian based family offices and Enterprise Ireland. The funding will enable Shorla to accelerate the growth of its oncology portfolio by advancing its pipeline, bringing therapies to

A Q&A guide to private equity law in Canada. The Q&A gives a high level overview of the key practical issues including the level of activity and recent trends in the mark...

Caribbean Utilities Company, Ltd. 2023 First Quarter Report March 31, 2023 Table of Contents ... | May 5, 2023

The "Global Property Insurance Market Size and Forecast to 2025- Overview, Key Trends, Drivers, Challenges, Regulatory Overview and Developments" report has been added to ResearchAndMarkets.com' s offering. This report provides in-depth market analysis, information, and insights into the global property insurance market and key regional property insurance...